Long-term altered immune responses following fetal priming in a non-human primate model of maternal immune activation

Brain, Behavior, and Immunity

Volumn 63, Issue , 2017, Pages 60-70

  Rose, Destanie R ^a,b   Careaga, Milo ^a,b   Van de Water, Judy ^b,c   McAllister, Kim ^b,c   Bauman, Melissa D ^a,b,d   Ashwood, Paul ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Autism; Behavior; Cytokines; Fetal priming; Maternal immune activation; Non human primate; schizophrenia

Indexed keywords

GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR; CYTOKINE; POLYINOSINIC POLYCYTIDYLIC ACID;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; FETUS; FIRST TRIMESTER PREGNANCY; IMMUNE DEFICIENCY; INFANT; INNATE IMMUNITY; MALE; MATERNAL IMMUNE ACTIVATION; NONHUMAN; PRIMING; PRIORITY JOURNAL; PROGENY; PSYCHOLOGY; RHESUS MONKEY; SECOND TRIMESTER PREGNANCY; TH2 CELL; ANIMAL; ANIMAL BEHAVIOR; DISEASE MODEL; DRUG EFFECTS; IMMUNE SYSTEM; IMMUNOLOGY; MOTOR ACTIVITY; PHYSIOLOGY; PREGNANCY; PREGNANCY COMPLICATION; PRENATAL EXPOSURE; STEREOTYPY;

ANIMALS; BEHAVIOR, ANIMAL; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; IMMUNE SYSTEM; INTERLEUKIN-13; INTERLEUKIN-4; MACACA MULATTA; MOTOR ACTIVITY; POLY I-C; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL EXPOSURE DELAYED EFFECTS; STEREOTYPED BEHAVIOR; TH2 CELLS;

EID: 85008311650     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2016.11.020     Document Type: Article

References (73)

1. Al-Amin, M.M., Uddin, M.M.N., Reza, H.M., Effects of antipsychotics on the inflammatory response system of patients with schizophrenia in peripheral blood mononuclear cell cultures. Clin. Psychopharmacol. Neurosci., 11(3), 2013, 144.
2. Al-Ayadhi, L.Y., Mostafa, G.A., Elevated serum levels of interleukin-17A in children with autism. J. Neuroinflammation, 9, 2012, 158.
3. Al-Ayadhi, L.Y., Mostafa, G.A., Elevated serum levels of macrophage-derived chemokine and thymus and activation-regulated chemokine in autistic children. J. Neuroinflammation, 10, 2013, 72.
4. Arend, W.P., Palmer, G., Gabay, C., IL-1, IL-18, and IL-33 families of cytokines. Immunol. Rev. 223:1 (2008), 20–38.
5. Asadabadi, M., Mohammadi, M.-R., Ghanizadeh, A., Modabbernia, A., Ashrafi, M., Hassanzadeh, E., Forghani, S., Akhondzadeh, S., Celecoxib as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial. Psychopharmacology 225:1 (2013), 51–59.
6. Ashwood, P., Enstrom, A., Krakowiak, P., Hertz-Picciotto, I., Hansen, R.L., Croen, L.A., Ozonoff, S., Pessah, I.N., Van de Water, J., Decreased transforming growth factor beta1 in autism: a potential link between immune dysregulation and impairment in clinical behavioral outcomes. J. Neuroimmunol. 204:1–2 (2008), 149–153.
7. Ashwood, P., Krakowiak, P., Hertz-Picciotto, I., Hansen, R., Pessah, I., Van de Water, J., Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. Brain Behav. Immun. 25:1 (2011), 40–45.
8. Ashwood, P., Krakowiak, P., Hertz-Picciotto, I., Hansen, R., Pessah, I.N., Van de Water, J., Altered T cell responses in children with autism. Brain Behav. Immun. 25:5 (2011), 840–849.
9. Ashwood, P., Krakowiak, P., Hertz-Picciotto, I., Hansen, R., Pessah, I.N., Van de Water, J., Associations of impaired behaviors with elevated plasma chemokines in autism spectrum disorders. J. Neuroimmunol. 232:1–2 (2011), 196–199.
10. Atladottir, H.O., Thorsen, P., Ostergaard, L., Schendel, D.E., Lemcke, S., Abdallah, M., Parner, E.T., Maternal infection requiring hospitalization during pregnancy and autism spectrum disorders. J. Autism Dev. Disord. 40:12 (2010), 1423–1430.
11. Bauman, M.D., Toscano, J.E., Babineau, B.A., Mason, W.A., Amaral, D.G., Emergence of stereotypies in juvenile monkeys (Macaca mulatta) with neonatal amygdala or hippocampus lesions. Behav. Neurosci. 122:5 (2008), 1005–1015.
12. Bauman, M.D., Iosif, A.M., Smith, S.E., Bregere, C., Amaral, D.G., Patterson, P.H., Activation of the maternal immune system during pregnancy alters behavioral development of rhesus monkey offspring. Biol. Psychiatry 75:4 (2014), 332–341.
13. Brown, A.S., Epidemiologic studies of exposure to prenatal infection and risk of schizophrenia and autism. Dev Neurobiol 72:10 (2012), 1272–1276.
14. Careaga, M., Rogers, S., Hansen, R.L., Amaral, D.G., Van de Water, J., Ashwood, P., Immune endophenotypes in children with autism spectrum disorder. Biol. Psychiatry, 2015.
15. Chang, S.W., Brent, L.J., Adams, G.K., Klein, J.T., Pearson, J.M., Watson, K.K., Platt, M.L., Neuroethology of primate social behavior. Proc. Natl. Acad. Sci. U.S.A. 110:Suppl. 2 (2013), 10387–10394.
16. Choi, G.B., Yim, Y.S., Wong, H., Kim, S., Kim, H., Kim, S.V., Hoeffer, C.A., Littman, D.R., Huh, J.R., The maternal interleukin-17a pathway in mice promotes autism-like phenotypes in offspring. Science, 2016.
17. Curran, L.K., Newschaffer, C.J., Lee, L.C., Crawford, S.O., Johnston, M.V., Zimmerman, A.W., Behaviors associated with fever in children with autism spectrum disorders. Pediatrics 120:6 (2007), e1386–e1392.
18. Dantzer, R., O'Connor, J.C., Freund, G.G., Johnson, R.W., Kelley, K.W., From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 9:1 (2008), 46–56.
19. Di Nicola, M., Cattaneo, A., Hepgul, N., Di Forti, M., Aitchison, K.J., Janiri, L., Murray, R.M., Dazzan, P., Pariante, C.M., Mondelli, V., Serum and gene expression profile of cytokines in first-episode psychosis. Brain Behav. Immun. 31 (2013), 90–95.
20. Emanuele, E., Orsi, P., Boso, M., Broglia, D., Brondino, N., Barale, F., di Nemi, S.U., Politi, P., Low-grade endotoxemia in patients with severe autism. Neurosci. Lett. 471:3 (2010), 162–165.
21. Enstrom, A.M., Onore, C.E., Van de Water, J.A., Ashwood, P., Differential monocyte responses to TLR ligands in children with autism spectrum disorders. Brain Behav. Immun. 24:1 (2010), 64–71.
22. Fearon, D.T., Locksley, R.M., The instructive role of innate immunity in the acquired immune response. Science, 272(5258), 1996, 50.
23. Frommberger, U.H., Bauer, J., Haselbauer, P., Fraulin, A., Riemann, D., Berger, M., Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission. Eur. Arch. Psychiatry Clin. Neurosci. 247:4 (1997), 228–233.
24. Garay, P.A., Hsiao, E.Y., Patterson, P.H., McAllister, A.K., Maternal immune activation causes age- and region-specific changes in brain cytokines in offspring throughout development. Brain Behav. Immun. 31 (2013), 54–68.
25. Garbett, K., Ebert, P.J., Mitchell, A., Lintas, C., Manzi, B., Mirnics, K., Persico, A.M., Immune transcriptome alterations in the temporal cortex of subjects with autism. Neurobiol. Dis. 30:3 (2008), 303–311.
26. Garbett, K.A., Hsiao, E.Y., Kalman, S., Patterson, P.H., Mirnics, K., Effects of maternal immune activation on gene expression patterns in the fetal brain. Transl. Psychiatry, 2, 2012, e98.
27. Han, X., Li, N., Meng, Q., Shao, Q., Wang, W., Maternal immune activation impairs reversal learning and increases serum tumor necrosis factor-α in offspring. Neuropsychobiology 64:1 (2011), 9–14.
28. Hsiao, E.Y., Patterson, P.H., Activation of the maternal immune system induces endocrine changes in the placenta via IL-6. Brain Behav. Immun. 25:4 (2011), 604–615.
29. Hsiao, E.Y., McBride, S.W., Chow, J., Mazmanian, S.K., Patterson, P.H., Modeling an autism risk factor in mice leads to permanent immune dysregulation. Proc. Natl. Acad. Sci. U.S.A. 109:31 (2012), 12776–12781.
30. Ito, H.T., Smith, S.E., Hsiao, E., Patterson, P.H., Maternal immune activation alters nonspatial information processing in the hippocampus of the adult offspring. Brain Behav. Immun. 24:6 (2010), 930–941.
31. Jones, S.A., Richards, P.J., Scheller, J., Rose-John, S., Review: IL-6 transsignaling: the in vivo consequences. J. Interferon Cytokine Res., 25(5), 2005, 241.
32. Jyonouchi, H., Geng, L., Davidow, A.L., Cytokine profiles by peripheral blood monocytes are associated with changes in behavioral symptoms following immune insults in a subset of ASD subjects: an inflammatory subtype?. J. Neuroinflammation, 11, 2014, 187.
33. Lin, A., Kenis, G., Bignotti, S., Tura, G.J.B., De Jong, R., Bosmans, E., Pioli, R., Altamura, C., Scharpé, S., Maes, M., The inflammatory response system in treatment-resistant schizophrenia: increased serum interleukin-6. Schizophr. Res. 32:1 (1998), 9–15.
34. Machado, C.J., Whitaker, A.M., Smith, S.E.P., Patterson, P.H., Bauman, M.D., Maternal immune activation in nonhuman primates alters social attention in juvenile offspring. Biol. Psychiatry 77:9 (2015), 823–832.
35. Maes, M., Bosmans, E., Calabrese, J., Smith, R., Meltzer, H.Y., Interleukin-2 and interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stabilizers. J. Psychiatr. Res. 29:2 (1995), 141–152.
36. Malkova, N.V., Yu, C.Z., Hsiao, E.Y., Moore, M.J., Patterson, P.H., Maternal immune activation yields offspring displaying mouse versions of the three core symptoms of autism. Brain Behav. Immun. 26:4 (2012), 607–616.
37. Mandal, M., Marzouk, A.C., Donnelly, R., Ponzio, N.M., Maternal immune stimulation during pregnancy affects adaptive immunity in offspring to promote development of TH17 cells. Brain Behav. Immun. 25:5 (2011), 863–871.
38. Mandal, M., Donnelly, R., Elkabes, S., Zhang, P., Davini, D., David, B.T., Ponzio, N.M., Maternal immune stimulation during pregnancy shapes the immunological phenotype of offspring. Brain Behav. Immun. 33 (2013), 33–45.
39. McAllister, A.K., Major Histocompatibility Complex I in Brain Development and Schizophrenia. Biol. Psychiatry 75:4 (2014), 262–268.
40. Medzhitov, R., Toll-like receptors and innate immunity. Nat. Rev. Immunol. 1:2 (2001), 135–145.
41. Meyer, U., Prenatal poly(i:C) exposure and other developmental immune activation models in rodent systems. Biol. Psychiatry 75:4 (2014), 307–315.
42. Meyer, U., Feldon, J., Epidemiology-driven neurodevelopmental animal models of schizophrenia. Prog. Neurobiol. 90:3 (2010), 285–326.
43. Meyer, U., Feldon, J., Schedlowski, M., Yee, B.K., Immunological stress at the maternal–foetal interface: a link between neurodevelopment and adult psychopathology. Brain Behav. Immun. 20:4 (2006), 378–388.
44. Meyer, U., Nyffeler, M., Engler, A., Urwyler, A., Schedlowski, M., Knuesel, I., Yee, B.K., Feldon, J., The time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathology. J. Neurosci. 26:18 (2006), 4752–4762.
45. Meyer, U., Murray, P.J., Urwyler, A., Yee, B.K., Schedlowski, M., Feldon, J., Adult behavioral and pharmacological dysfunctions following disruption of the fetal brain balance between pro-inflammatory and IL-10-mediated anti-inflammatory signaling. Mol. Psychiatry 13:2 (2008), 208–221.
46. Meyer, U., Feldon, J., Fatemi, S.H., In-vivo rodent models for the experimental investigation of prenatal immune activation effects in neurodevelopmental brain disorders. Neurosci. Biobehav. Rev. 33:7 (2009), 1061–1079.
47. Mittleman, B.B., Castellanos, F.X., Jacobsen, L.K., Rapoport, J.L., Swedo, S.E., Shearer, G.M., Cerebrospinal fluid cytokines in pediatric neuropsychiatric disease. J. Immunol. 159:6 (1997), 2994–2999.
48. Muller, N., Schwarz, M.J., Immune System and Schizophrenia. Curr. Immunol. Rev. 6:3 (2010), 213–220.
49. Müller, N., Schlesinger, B., Hadjamu, M., Riedel, M., Schwarz, M., Ackenheil, M., Wank, R., Gruber, R., Increased frequency of CD8 positive gamma/delta T-lymphocytes (CD8+ γ/δ+) in unmedicated schizophrenic patients: relation to impairment of the blood–brain barrier and HLA-DPA∗ 02011. Schizophr. Res. 32:1 (1998), 69–71.
50. Müller, N., Riedel, M., Gruber, R., Ackenheil, M., Schwarz, M.J., The Immune system and schizophrenia: an integrative view. Ann. N.Y. Acad. Sci. 917:1 (2000), 456–467.
51. Okada, K., Hashimoto, K., Iwata, Y., Nakamura, K., Tsujii, M., Tsuchiya, K.J., Sekine, Y., Suda, S., Suzuki, K., Sugihara, G., Matsuzaki, H., Sugiyama, T., Kawai, M., Minabe, Y., Takei, N., Mori, N., Decreased serum levels of transforming growth factor-beta1 in patients with autism. Prog. Neuropsychopharmacol. Biol. Psychiatry 31:1 (2007), 187–190.
52. Onore, C., Careaga, M., Ashwood, P., The role of immune dysfunction in the pathophysiology of autism. Brain Behav. Immun. 26:3 (2012), 383–392.
53. Onore, C.E., Schwartzer, J.J., Careaga, M., Berman, R.F., Ashwood, P., Maternal immune activation leads to activated inflammatory macrophages in offspring. Brain Behav. Immun. 38 (2014), 220–226.
54. Patterson, P.H., Immune involvement in schizophrenia and autism: etiology, pathology and animal models. Behav. Brain Res. 204:2 (2009), 313–321.
55. Pomerantz, O., Paukner, A., Terkel, J., Some stereotypic behaviors in rhesus macaques (Macaca mulatta) are correlated with both perseveration and the ability to cope with acute stressors. Behav. Brain Res. 230:1 (2012), 274–280.
56. Potvin, S., Stip, E., Sepehry, A.A., Gendron, A., Bah, R., Kouassi, E., Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review. Biol. Psychiatry 63:8 (2008), 801–808.
57. Rasmussen, S.A., Jamieson, D.J., Honein, M.A., Petersen, L.R., Zika Virus and Birth Defects — Reviewing the Evidence for Causality. N. Engl. J. Med. 374:20 (2016), 1981–1987.
58. Ricci, S., Businaro, R., Ippoliti, F., Lo Vasco, V.R., Massoni, F., Onofri, E., Troili, G.M., Pontecorvi, V., Morelli, M., Rapp Ricciardi, M., Archer, T., Altered cytokine and BDNF levels in autism spectrum disorder. Neurotox. Res. 24:4 (2013), 491–501.
59. Rose, D., Ashwood, P., Potential cytokine biomarkers in autism spectrum disorders. Biomark Med. 8:9 (2014), 1171–1181.
60. Schwartzer, J.J., Careaga, M., Onore, C.E., Rushakoff, J.A., Berman, R.F., Ashwood, P., Maternal immune activation and strain specific interactions in the development of autism-like behaviors in mice. Transl. Psychiatry, 3, 2013, e240.
61. Shi, L., Tu, N., Patterson, P.H., Maternal influenza infection is likely to alter fetal brain development indirectly: the virus is not detected in the fetus. Int. J. Dev. Neurosci. 23:2–3 (2005), 299–305.
62. Shi, L., Smith, S.E.P., Malkova, N., Tse, D., Su, Y., Patterson, P.H., Activation of the Maternal Immune System Alters Cerebellar Development in the Offspring. Brain Behav. Immun. 23:1 (2009), 116–123.
63. Short, S.J., Lubach, G.R., Karasin, A.I., Olsen, C.W., Styner, M., Knickmeyer, R.C., Gilmore, J.H., Coe, C.L., Maternal influenza infection during pregnancy impacts postnatal brain development in the rhesus monkey. Biol. Psychiatry 67:10 (2010), 965–973.
64. Singh, V.K., Plasma increase of interleukin-12 and interferon-gamma. Pathological significance in autism. J. Neuroimmunol. 66:1–2 (1996), 143–145.
65. Smith, S.E., Li, J., Garbett, K., Mirnics, K., Patterson, P.H., Maternal immune activation alters fetal brain development through interleukin-6. J. Neurosci. 27:40 (2007), 10695–10702.
66. Spinelli, S., Schwandt, M.L., Lindell, S.G., Heilig, M., Suomi, S.J., Higley, J.D., Goldman, D., Barr, C.S., The serotonin transporter gene linked polymorphic region is associated with the behavioral response to repeated stress exposure in infant rhesus macaques. Dev. Psychopathol. 24:1 (2012), 157–165.
67. Suzuki, K., Matsuzaki, H., Iwata, K., Kameno, Y., Shimmura, C., Kawai, S., Yoshihara, Y., Wakuda, T., Takebayashi, K., Takagai, S., Matsumoto, K., Tsuchiya, K.J., Iwata, Y., Nakamura, K., Tsujii, M., Sugiyama, T., Mori, N., Plasma cytokine profiles in subjects with high-functioning autism spectrum disorders. PLoS One, 6(5), 2011, e20470.
68. Trinchieri, G., Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13 (1995), 251–276.
69. van Kammen, D.P., McAllister, C.G., Kelley, M.E., Relationship between immune and behavioral measures in schizophrenia. Current Update in Psychoimmunology, 1997, G. Wieselmann. Vienna, Springer Vienna, 51–55.
70. Watson, K.K., Platt, M.L., Of mice and monkeys: using non-human primate models to bridge mouse- and human-based investigations of autism spectrum disorders. J Neurodev Disord, 4(1), 2012, 21.
71. Weir, R.K., Forghany, R., Smith, S.E., Patterson, P.H., McAllister, A.K., Schumann, C.M., Bauman, M.D., Preliminary evidence of neuropathology in nonhuman primates prenatally exposed to maternal immune activation. Brain Behav. Immun. 48 (2015), 139–146.
72. Wilke, I., Arolt, V., Rothermundt, M., Weitzsch, C., Hornberg, M., Kirchner, H., Investigations of cytokine production in whole blood cultures of paranoid and residual schizophrenic patients. Eur. Arch. Psychiatry Clin. Neurosci. 246:5 (1996), 279–284.
73. Willette, A.A., Lubach, G.R., Knickmeyer, R.C., Short, S.J., Styner, M., Gilmore, J.H., Coe, C.L., Brain enlargement and increased behavioral and cytokine reactivity in infant monkeys following acute prenatal endotoxemia. Behav. Brain Res. 219:1 (2011), 108–115.